MedTrace Logo

A Phase IV Study, of the Efficacy, Safety, and Acceptability of Moviprep® Versus Colopeg® in Colonoscopy Preparation

NCT00605228 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2008-01-30

No results posted yet for this study

Summary

Primary:

\- To demonstrate the superiority of Moviprep® versus Colopeg® in gut cleansing prior to colonoscopy.

Secondary:

* To assess the safety of Moviprep® versus Colopeg®.
* To assess acceptability of Moviprep® versus Colopeg®.

Conditions

  • Gastrointestinal Diseases

Interventions

DRUG

MOVIPREP

2L Drug

DRUG

COLOPEG

4L Drug

Sponsors & Collaborators

  • International Clinical Trials Association

    collaborator OTHER

  • Norgine

    lead INDUSTRY

Principal Investigators

  • Thierry PONCHON, MD · HOPITAL EDOUARD HERRIOT

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-05-31
Primary Completion
2007-12-31
Completion
2007-12-31

Countries

  • France

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00605228 on ClinicalTrials.gov